Vicus Capital Decreases Position in The Procter & Gamble Company (NYSE:PG)

Vicus Capital decreased its position in shares of The Procter & Gamble Company (NYSE:PG) by 44.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,930 shares of the company’s stock after selling 2,330 shares during the quarter. Vicus Capital’s holdings in Procter & Gamble were worth $508,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in PG. Traphagen Investment Advisors LLC increased its holdings in Procter & Gamble by 8.1% in the 3rd quarter. Traphagen Investment Advisors LLC now owns 4,864 shares of the company’s stock worth $842,000 after buying an additional 365 shares in the last quarter. Home Federal Bank of Tennessee boosted its holdings in shares of Procter & Gamble by 0.8% during the 3rd quarter. Home Federal Bank of Tennessee now owns 23,515 shares of the company’s stock valued at $4,073,000 after acquiring an additional 197 shares during the last quarter. Calton & Associates Inc. boosted its holdings in shares of Procter & Gamble by 38.8% during the 3rd quarter. Calton & Associates Inc. now owns 3,536 shares of the company’s stock valued at $612,000 after acquiring an additional 989 shares during the last quarter. Foundations Investment Advisors LLC raised its holdings in shares of Procter & Gamble by 9.5% during the third quarter. Foundations Investment Advisors LLC now owns 52,245 shares of the company’s stock valued at $9,049,000 after purchasing an additional 4,543 shares during the last quarter. Finally, Ledyard National Bank lifted its position in Procter & Gamble by 2.0% during the third quarter. Ledyard National Bank now owns 90,667 shares of the company’s stock valued at $15,704,000 after purchasing an additional 1,797 shares during the period. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday. JPMorgan Chase & Co. upped their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and cut their target price for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. TD Cowen started coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target on the stock. Finally, DA Davidson boosted their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Price Performance

Shares of NYSE:PG traded up $0.82 during midday trading on Tuesday, reaching $170.36. 2,762,308 shares of the company were exchanged, compared to its average volume of 6,667,838. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The stock has a market cap of $402.07 billion, a PE ratio of 27.76, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41. The business’s fifty day moving average is $171.82 and its two-hundred day moving average is $167.33. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter last year, the business posted $1.83 earnings per share. As a group, analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.36%. Procter & Gamble’s dividend payout ratio (DPR) is 65.69%.

Insider Activity

In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is currently owned by insiders.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.